Agrin and neuregulin, expanding roles and implications for therapeutics

Biotechnology Advances

Volumn 26, Issue 3, 2008, Pages 187-201

  Williams, Stacey ^a   Ryan, Colleen ^a   Jacobson, Christian ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Agrin; Development; Disease; Neuregulin; Synapse formation

Indexed keywords

DISEASE CONTROL; GENES; NEUROLOGY; TUMORS;

BREAST CANCER; SYNAPSE FORMATION;

MOLECULAR STRUCTURE;

AGRIN; NEU DIFFERENTIATION FACTOR;

CANCER; DRUG DEVELOPMENT; NERVOUS SYSTEM;

ANIMAL; BIOLOGICAL MODEL; DUCHENNE MUSCULAR DYSTROPHY; GENETICS; HEART FAILURE; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

AGRIN; ANIMALS; HEART FAILURE; HUMANS; MODELS, BIOLOGICAL; MUSCULAR DYSTROPHY, DUCHENNE; NEOPLASMS; NEUREGULINS;

EID: 41349123687     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2007.11.003     Document Type: Review

References (226)

1. Alfsen A., Yu H., Magerus-Chatinet A., Schmitt A., and Bomsel M. HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Mol Biol Cell 16 (2005) 4267-4279
2. Altiok N., Altiok S., and Changeux J.P. Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity. EMBO J 16 (1997) 717-725
3. Annies M., Bittcher G., Ramseger R., Loschinger J., Woll S., Porten E., et al. Clustering transmembrane-agrin induces filopodia-like processes on axons and dendrites. Mol Cell Neurosci 31 (2006) 515-524
4. Anton E.S., Marchionni M.A., Lee K.F., and Rakic P. Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. Development 124 (1997) 3501-3510
5. Atlas E., Cardillo M., Mehmi I., Zahedkargaran H., Tang C., and Lupu R. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo. Mol Cancer Res 1 (2003) 165-175
6. Baselga J. Clinical trials of single-agent trastuzumab (Herceptin). Semin Oncol 27 (2000) 20-26
7. Baselga J. Current and planned clinical trials with trastuzumab (Herceptin). Semin Oncol 27 (2000) 27-32
8. Ben-Baruch N., and Yarden Y. Neu differentiation factors: a family of alternatively spliced neuronal and mesenchymal factors. Proc Soc Exp Biol Med 206 (1994) 221-227
9. Bentzinger C.F., Barzaghi P., Lin S., and Ruegg M.A. Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice. FASEB J 19 (2005) 934-942
10. Berger M.S., Locher G.W., Saurer S., Gullick W.J., Waterfield M.D., Groner B., et al. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48 (1988) 1238-1243
11. Bermingham-McDonogh O., McCabe K.L., and Reh T.A. Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina. Development 122 (1996) 1427-1438
12. Berzin T.M., Zipser B.D., Rafii M.S., Kuo-Leblanc V., Yancopoulos G.D., Glass D.J., et al. Agrin and microvascular damage in Alzheimer's disease. Neurobiol Aging 21 (2000) 349-355
13. Bezakova G., and Ruegg M.A. New insights into the roles of agrin. Nat Rev Mol Cell Biol 4 (2003) 295-308
14. Biroc S.L., Payan D.G., and Fisher J.M. Isoforms of agrin are widely expressed in the developing rat and may function as protease inhibitors. J Biol Chem 268 (1993) 25108-25117
15. Bixby J.L., Baerwald-De la Torre K., Wang C., Rathjen F.G., and Ruegg M.A. A neuronal inhibitory domain in the N-terminal half of agrin. J Neurobiol 50 (2002) 164-179
16. Black I.B. Trophic regulation of synaptic plasticity. J Neurobiol 41 (1999) 108-118
17. Blouin J.L., Dombroski B.A., Nath S.K., Lasseter V.K., Wolyniec P.S., Nestadt G., et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 20 (1998) 70-73
18. Bose C.M., Qiu D., Bergamaschi A., Gravante B., Bossi M., Villa A., et al. Agrin controls synaptic differentiation in hippocampal neurons. J Neurosci 20 (2000) 9086-9095
19. Bowe M.A., Deyst K.A., Leszyk J.D., and Fallon J.R. Identification and purification of an agrin receptor from Torpedo postsynaptic membranes: a heteromeric complex related to the dystroglycans. Neuron 12 (1994) 1173-1180
20. Brines M.L., Dare A.O., and de Lanerolle N.C. The cardiac glycoside ouabain potentiates excitotoxic injury of adult neurons in rat hippocampus. Neurosci Lett 191 (1995) 145-148
21. Britsch S. The neuregulin-I/ErbB signaling system in development and disease. Adv Anat Embryol Cell Biol 190 (2007) 1-65
22. Brown N., Deb K., Paria B.C., Das S.K., and Reese J. Embryo-uterine interactions via the neuregulin family of growth factors during implantation in the mouse. Biol Reprod 71 (2004) 2003-2011
23. Buonanno A., and Fischbach G.D. Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr Opin Neurobiol 11 (2001) 287-296
24. Burden S.J. Synapse-specific gene expression. Trends Genet 9 (1993) 12-16
25. Burden S., and Yarden Y. Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron 18 (1997) 847-855
26. 2+ channel subunit compositions in lethargic mouse brain. Mol Cell Neurosci 13 (1999) 293-311
27. Burgess R.W., Skarnes W.C., and Sanes J.R. Agrin isoforms with distinct amino termini: differential expression, localization, and function. J Cell Biol 151 (2000) 41-52
28. Calaora V., Rogister B., Bismuth K., Murray K., Brandt H., Leprince P., et al. Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J Neurosci 21 (2001) 4740-4751
29. Campagna J.A., Ruegg M.A., and Bixby J.L. Agrin is a differentiation-inducing "stop signal" for motoneurons in vitro. Clin Exp Pharmacol Physiol 22 (1995) 961-965
30. Campanelli J.T., Roberds S.L., Campbell K.P., and Scheller R.H. A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell 77 (1994) 663-674
31. Campbell K.P., and Kahl S.D. Association of dystrophin and an integral membrane glycoprotein. Nature 338 (1989) 259-262
32. Cannella B., Hoban C.J., Gao Y.L., Garcia-Arenas R., Lawson D., Marchionni M., et al. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc Natl Acad Sci U S A 95 (1998) 10100-10105
33. Cannella B., Pitt D., Marchionni M., and Raine C.S. Neuregulin and erbB receptor expression in normal and diseased human white matter. J Neuroimmunol 100 (1999) 233-242
34. Canoll P.D., Musacchio J.M., Hardy R., Reynolds R., Marchionni M.A., and Salzer J.L. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17 (1996) 229-243
35. Carraway III K.L., Weber J.L., Unger M.J., Ledesma J., Yu N., Gassmann M., et al. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 387 (1997) 512-516
36. Chaudhury A.R., Gerecke K.M., Wyss J.M., Morgan D.G., Gordon M.N., and Carroll S.L. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J Neuropathol Exp Neurol 62 (2003) 42-54
37. Chen M.S., Bermingham-McDonogh O., Danehy Jr. F.T., Nolan C., Scherer S.S., Lucas J., et al. Expression of multiple neuregulin transcripts in postnatal rat brains. J Comp Neurol 349 (1994) 389-400
38. Chen S., Velardez M.O., Warot X., Yu Z.X., Miller S.J., Cros D., et al. Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function. J Neurosci 26 (2006) 3079-3086
39. Cote P., Lindenbaum M.H., and Carbonetto S. Dystroglycan is essential for early embryonic development. Mol Biol Cell 8 (1997) 1283
40. Cote P.D., Moukhles H., Lindenbaum M., and Carbonetto S. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet 23 (1999) 338-342
41. Cotman S.L., Halfter W., and Cole G.J. Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol Cell Neurosci 15 (2000) 183-198
42. Crone S.A., Zhao Y.Y., Fan L., Gu Y., Minamisawa S., Liu Y., et al. ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med 8 (2002) 459-465
43. Curigliano G., Spitaleri G., Pietri E., Rescigno M., de Braud F., Cardillo A., et al. Breast cancer vaccines: a clinical reality or fairy tale?. Ann Oncol 17 (2006) 750-762
44. Dammann C.E., Nielsen H.C., and Carraway III K.L. Role of neuregulin-1 beta in the developing lung. Am J Respir Crit Care Med 167 (2003) 1711-1716
45. Davies A.M., and Wright E.M. Neurotrophic factors. Neurotrophin autocrine loops. Curr Biol 5 (1995) 723-726
46. +-ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 43 (2004) 169-175
47. DeChiara T.M., Bowen D.C., Valenzuela D.M., Simmons M.V., Poueymirou W.T., Thomas S., et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85 (1996) 501-512
48. Deconinck N., and Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 36 (2007) 1-7
49. Dennis C.L., Tinsley J.M., Deconinck A.E., and Davies K.E. Molecular and functional analysis of the utrophin promoter. Nucleic Acids Res 24 (1996) 1646-1652
50. Denzer A.J., Gesemann M., Schumacher B., and Ruegg M.A. An amino-terminal extension is required for the secretion of chick agrin and its binding to extracellular matrix. Neuron 15 (1995) 1365-1374
51. Denzer A.J., Hauser D.M., Gesemann M., and Ruegg M.A. Synaptic differentiation: the role of agrin in the formation and maintenance of the neuromuscular junction. Histochem Cell Biol 108 (1997) 249-255
52. Dimitropoulou A., and Bixby J.L. Motor neurite outgrowth is selectively inhibited by cell surface MuSK and agrin. Mol Cell Neurosci 28 (2005) 292-302
53. Disis M.L., Shiota F.M., and Cheever M.A. Human HER-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for 'self' tumour antigens. Immunology 93 (1998) 192-199
54. Disis M.L., Grabstein K.H., Sleath P.R., and Cheever M.A. Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine. Clin Cancer Res 5 (1999) 1289-1297
55. Dong Z., Brennan A., Liu N., Yarden Y., Lefkowitz G., Mirsky R., et al. Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. Neuron 15 (1995) 585-596
56. Durbeej M., and Campbell K.P. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 12 (2002) 349-361
57. Dustin M.L. Membrane domains and the immunological synapse: keeping T cells resting and ready. J Clin Invest 109 (2002) 155-160
58. Ehmsen J., Poon E., and Davies K. The dystrophin-associated protein complex. J Cell Sci 115 (2002) 2801-2803
59. Erickson S.L., O'Shea K.S., Ghaboosi N., Loverro L., Frantz G., Bauer M., et al. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development 124 (1997) 4999-5011
60. Ervasti J.M., and Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122 (1993) 809-823
61. Ervasti J.M., Ohlendieck K., Kahl S.D., Gaver M.G., and Campbell K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345 (1990) 315-319
62. Escher P., Lacazette E., Courtet M., Blindenbacher A., Landmann L., Bezakova G., et al. Synapses form in skeletal muscles lacking neuregulin receptors. Science 308 (2005) 1920-1923
63. Falls D.L. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284 (2003) 14-30
64. Ferns M., Hoch W., Campanelli J.T., Rupp F., Hall Z.W., and Scheller R.H. RNA splicing regulates agrin-mediated acetylcholine receptor clustering activity on cultured myotubes. Neuron 8 (1992) 1079-1086
65. Ferns M.J., Campanelli J.T., Hoch W., Scheller R.H., and Hall Z. The ability of agrin to cluster AChRs depends on alternative splicing and on cell surface proteoglycans. Neuron 11 (1993) 491-502
66. Ferreira A. Abnormal synapse formation in agrin-depleted hippocampal neurons. J Cell Sci 112 Pt 24 (1999) 4729-4738
67. Ferrer I., and Planas A.M. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J Neuropathol Exp Neurol 62 (2003) 329-339
68. Fischbach G.D., and Rosen K.M. ARIA: a neuromuscular junction neuregulin. Annu Rev Neurosci 20 (1997) 429-458
69. Flores A.I., Mallon B.S., Matsui T., Ogawa W., Rosenzweig A., Okamoto T., et al. Akt-mediated survival of oligodendrocytes induced by neuregulins. J Neurosci 20 (2000) 7622-7630
70. Fuerst P.G., Rauch S.M., and Burgess R.W. Defects in eye development in transgenic mice overexpressing the heparan sulfate proteoglycan agrin. Dev Biol 303 (2007) 165-180
71. Gadek J.E., and Pacht E.R. The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema. Lung 168 (1990) 552-564 [Suppl]
72. Garcia-Osta A., Tsokas P., Pollonini G., Landau E.M., Blitzer R., and Alberini C.M. MuSK expressed in the brain mediates cholinergic responses, synaptic plasticity, and memory formation. J Neurosci 26 (2006) 7919-7932
73. Garratt A.N., Voiculescu O., Topilko P., Charnay P., and Birchmeier C. A dual role of erbB2 in myelination and in expansion of the Schwann cell precursor pool. J Cell Biol 148 (2000) 1035-1046
74. Gascoigne N.R., and Zal T. Molecular interactions at the T cell-antigen-presenting cell interface. Curr Opin Immunol 16 (2004) 114-119
75. Gassmann M., Casagranda F., Orioli D., Simon H., Lai C., Klein R., et al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378 (1995) 390-394
76. Gautam M., Noakes P.G., Moscoso L., Rupp F., Scheller R.H., Merlie J.P., et al. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85 (1996) 525-535
77. Gee S.H., Montanaro F., Lindenbaum M.H., and Carbonetto S. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77 (1994) 675-686
78. Gesemann M., Denzer A.J., and Ruegg M.A. Acetylcholine receptor-aggregating activity of agrin isoforms and mapping of the active site. Dev Biol 167 (1995) 458-468
79. Gesemann M., Brancaccio A., Schumacher B., and Ruegg M.A. Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. J Biol Chem 273 (1998) 600-605
80. Gingras J., and Ferns M. Expression and localization of agrin during sympathetic synapse formation in vitro. J Neurobiol 48 (2001) 228-242
81. Gingras J., Rassadi S., Cooper E., and Ferns M. Agrin plays an organizing role in the formation of sympathetic synapses. J Cell Biol 158 (2002) 1109-1118
82. Glass D.J., Bowen D.C., Stitt T.N., Radziejewski C., Bruno J., Ryan T.E., et al. Agrin acts via a MuSK receptor complex. Cell 85 (1996) 513-523
83. Glass D.J., DeChiara T.M., Stitt T.N., DiStefano P.S., Valenzuela D.M., and Yancopoulos G.D. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation and is a functional receptor for agrin. FEBS Lett 379 (1996) 63-68
84. Goodearl A.D., Davis J.B., Mistry K., Minghetti L., Otsu M., Waterfield M.D., et al. Purification of multiple forms of glial growth factor. J Biol Chem 268 (1993) 18095-18102
85. Groffen A.J., Ruegg M.A., Dijkman H., van de Velden T.J., Buskens C.A., van den Born J., et al. Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Neurobiol 33 (1997) 999-1018
86. Groffen A.J., Buskens C.A., van Kuppevelt T.H., Veerkamp J.H., Monnens L.A., and van den Heuvel L.P. Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur J Biochem 254 (1998) 123-128
87. Groffen A.J., Veerkamp J.H., Monnens L.A., and van den Heuvel L.P. Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane [In Process Citation]. Nephrol Dial Transplant 14 (1999) 2119-2129
88. Gu Z., Jiang Q., Fu A.K., Ip N.Y., and Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 25 (2005) 4974-4984
89. Guo W.P., Wang J., Li R.X., and Peng Y.W. Neuroprotective effects of neuregulin-1 in rat models of focal cerebral ischemia. Brain Res 1087 (2006) 180-185
90. Haenggi T., and Fritschy J.M. Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue. Cell Mol Life Sci 63 (2006) 1614-1631
91. Haenggi T., Schaub M.C., and Fritschy J.M. Molecular heterogeneity of the dystrophin-associated protein complex in the mouse kidney nephron: differential alterations in the absence of utrophin and dystrophin. Cell Tissue Res 319 (2005) 299-313
92. Halfter W., Schurer B., Yip J., Yip L., Tsen G., Lee J.A., et al. Distribution and substrate properties of agrin, a heparan sulfate proteoglycan of developing axonal pathways. Neuroscience 79 (1997) 191-201
93. Harari D., Tzahar E., Romano J., Shelly M., Pierce J.H., Andrews G.C., et al. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene 18 (1999) 2681-2689
94. Harisi R., Dudas J., Timar F., Pogany G., Paku S., Timar J., et al. Antiproliferative and antimigratory effects of doxorubicin in human osteosarcoma cells exposed to extracellular matrix. Anticancer Res 25 (2005) 805-813
95. Hausser H.J., Ruegg M.A., Brenner R.E., and Ksiazek I. Agrin is highly expressed by chondrocytes and is required for normal growth. Histochem Cell Biol 127 (2007) 363-374
96. Henry M.D., and Campbell K.P. A role for dystroglycan in basement membrane assembly. Cell 95 (1998) 859-870
97. 2+ that engages both CaMKII and MAPK signal pathways. J Neurobiol 61 (2004) 289-300
98. Hilgenberg L.G., Ho K.D., Lee D., O'Dowd D.K., and Smith M.A. Agrin regulates neuronal responses to excitatory neurotransmitters in vitro and in vivo. Mol Cell Neurosci 19 (2002) 97-110
99. +-ATPase is a neuronal receptor for agrin. Cell 125 (2006) 359-369
100. Hippenmeyer S., Shneider N.A., Birchmeier C., Burden S.J., Jessell T.M., and Arber S. A role for neuregulin1 signaling in muscle spindle differentiation. Neuron 36 (2002) 1035-1049
101. Ho W.H., Armanini M.P., Nuijens A., Phillips H.S., and Osheroff P.L. Sensory and motor neuron-derived factor. A novel heregulin variant highly expressed in sensory and motor neurons. J Biol Chem 270 (1995) 14523-14532
102. Hoch W., Ferns M., Campanelli J.T., Hall Z.W., and Scheller R.H. Developmental regulation of highly active alternatively spliced forms of agrin. Neuron 11 (1993) 479-490
103. Hoch W., Campanelli J.T., Harrison S., and Scheller R.H. Structural domains of agrin required for clustering of nicotinic acetylcholine receptors. J Cell Biol 126 (1994) 1-4
104. Holmes W.E., Sliwkowski M.X., Akita R.W., Henzel W.J., Lee J., Park J.W., et al. Identification of heregulin, a specific activator of p185erbB2. Science 256 (1992) 1205-1210
105. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., and Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355 (1992) 696-702
106. Jacobelli J., Andres P.G., Boisvert J., and Krummel M.F. New views of the immunological synapse: variations in assembly and function. Curr Opin Immunol 16 (2004) 345-352
107. Jacobson C., Montanaro F., Lindenbaum M., Carbonetto S., and Ferns M. alpha-Dystroglycan functions in acetylcholine receptor aggregation but is not a coreceptor for agrin-MuSK signaling. J Neurosci 18 (1998) 6340-6348
108. Jacobson C., Cote P.D., Rossi S.G., Rotundo R.L., and Carbonetto S. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J Cell Biol 152 (2001) 435-450
109. Jacobson C., Duggan D., and Fischbach G. Neuregulin induces the expression of transcription factors and myosin heavy chains typical of muscle spindles in cultured human muscle. Proc Natl Acad Sci U S A 101 (2004) 12218-12223
110. Jaworski A., and Burden S.J. Neuromuscular synapse formation in mice lacking motor neuron- and skeletal muscle-derived Neuregulin-1. J Neurosci 26 (2006) 655-661
111. Jessell T.M., Siegel R.E., and Fischbach G.D. Induction of acetylcholine receptors on cultured skeletal muscle by a factor extracted from brain and spinal cord. Proc Natl Acad Sci U S A 76 (1979) 5397-5401
112. Jessen K.R., and Mirsky R. The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 6 (2005) 671-682
113. Jo S.A., Zhu X., Marchionni M.A., and Burden S.J. Neuregulins are concentrated at nerve-muscle synapses and activate ACh- receptor gene expression. Nature 373 (1995) 158-161
114. Khan A.A., Bose C., Yam L.S., Soloski M.J., and Rupp F. Physiological regulation of the immunological synapse by agrin. Science 292 (2001) 1681-1686
115. Kim JH, Huganir RL, Organization and regulation of proteins at synapses [published erratum appears in Curr Opin Cell Biol 1999 Jun;11(3):407-8]. Curr Opin Cell Biol 1999;11:248-54.
116. Kim D., Chi S., Lee K.H., Rhee S., Kwon Y.K., Chung C.H., et al. Neuregulin stimulates myogenic differentiation in an autocrine manner. J Biol Chem 274 (1999) 15395-15400
117. Kim M.J., Liu I.H., Song Y., Lee J.A., Halfter W., Balice-Gordon R.J., et al. Agrin is required for posterior development and motor axon outgrowth and branching in embryonic zebrafish. Glycobiology 17 (2007) 231-247
118. Kopp D.M., Trachtenberg J.T., and Thompson W.J. Glial growth factor rescues Schwann cells of mechanoreceptors from denervation-induced apoptosis. J Neurosci 17 (1997) 6697-6706
119. Koulen P., Honig L.S., Fletcher E.L., and Kroger S. Expression, distribution and ultrastructural localization of the synapse-organizing molecule agrin in the mature avian retina. Eur J Neurosci 11 (1999) 4188-4196
120. Kramer R., Bucay N., Kane D.J., Martin L.E., Tarpley J.E., and Theill L.E. Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. Proc Natl Acad Sci U S A 93 (1996) 4833-4838
121. Kroger S. Differential distribution of agrin isoforms in the developing and adult avian retina. Mol Cell Neurosci 10 (1997) 149-161
122. Kuang W., Xu H., Vachon P.H., Liu L., Loechel F., Wewer U.M., et al. Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models [published erratum appears in J Clin Invest 1998 Sep 15;102(6):following 1275]. J Clin Invest 102 (1998) 844-852
123. Kumar P., Ferns M.J., and Meizel S. Identification of agrinSN isoform and muscle-specific receptor tyrosine kinase (MuSK) [corrected] in sperm. Biochem Biophys Res Commun 342 (2006) 522-528
124. Kummer T.T., Misgeld T., and Sanes J.R. Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost. Curr Opin Neurobiol 16 (2006) 74-82
125. Law A.J., Shannon Weickert C., Hyde T.M., Kleinman J.E., and Harrison P.J. Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience 127 (2004) 125-136
126. Lee K.F., Simon H., Chen H., Bates B., Hung M.C., and Hauser C. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378 (1995) 394-398
127. Lemke G. Neuregulins in development. Mol Cell Neurosci 7 (1996) 247-262
128. Lewis D.A., and Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 63 (2006) 1372-1376
129. Li L., Cleary S., Mandarano M.A., Long W., Birchmeier C., and Jones F.E. The breast proto-oncogene, HRGalpha regulates epithelial proliferation and lobuloalveolar development in the mouse mammary gland. Oncogene 21 (2002) 4900-4907
130. Li B., Woo R.S., Mei L., and Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54 (2007) 583-597
131. Liu Y., Ford B., Mann M.A., and Fischbach G.D. Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J Neurosci 21 (2001) 5660-5669
132. Liu J., Nethery D., and Kern J.A. Neuregulin-1 induces branching morphogenesis in the developing lung through a P13K signal pathway. Exp Lung Res 30 (2004) 465-478
133. Liu C.M., Hwu H.G., Fann C.S., Lin C.Y., Liu Y.L., Ou-Yang W.C., et al. Linkage evidence of schizophrenia to loci near neuregulin 1 gene on chromosome 8p21 in Taiwanese families. Am J Med Genet B Neuropsychiatr Genet 134 (2005) 79-83
134. Liu X., Gu X., Li Z., Li X., Li H., Chang J., et al. Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J Am Coll Cardiol 48 (2006) 1438-1447
135. Lovering R.M., Porter N.C., and Bloch R.J. The muscular dystrophies: from genes to therapies. Phys Ther 85 (2005) 1372-1388
136. Ma Y.J., Hill D.F., Creswick K.E., Costa M.E., Cornea A., Lioubin M.N., et al. Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development. J Neurosci 19 (1999) 9913-9927
137. Mahanthappa N.K., Anton E.S., and Matthew W.D. Glial growth factor 2, a soluble neuregulin, directly increases Schwann cell motility and indirectly promotes neurite outgrowth. J Neurosci 16 (1996) 4673-4683
138. Marchionni M.A., Goodearl A.D., Chen M.S., Bermingham-McDonogh O., Kirk C., Hendricks M., et al. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362 (1993) 312-318
139. McCroskery S., Chaudhry A., Lin L., and Daniels M.P. Transmembrane agrin regulates filopodia in rat hippocampal neurons in culture. Mol Cell Neurosci 33 (2006) 15-28
140. McMahan U.J. The agrin hypothesis. J Physiol (Paris) 84 (1990) 78-81
141. Meier T., Hauser D.M., Chiquet M., Landmann L., Ruegg M.A., and Brenner H.R. Neural agrin induces ectopic postsynaptic specializations in innervated muscle fibers. J Neurosci 17 (1997) 6534-6544
142. Merlie J.P., and Sanes J.R. Concentration of acetylcholine receptor mRNA in synaptic regions of adult muscle fibres. Nature 317 (1985) 66-68
143. Meyer D., and Birchmeier C. Multiple essential functions of neuregulin in development. Nature 378 (1995) 386-390
144. Michailov G.V., Sereda M.W., Brinkmann B.G., Fischer T.M., Haug B., Birchmeier C., et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science 304 (2004) 700-703
145. Miyagoe Y., Hanaoka K., Nonaka I., Hayasaka M., Nabeshima Y., Arahata K., et al. Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 415 (1997) 33-39
146. Moll J., Barzaghi P., Lin S., Bezakova G., Lochmuller H., Engvall E., et al. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature 413 (2001) 302-307
147. Muss H.B., Thor A.D., Berry D.A., Kute T., Liu E.T., Koerner F., et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 330 (1994) 1260-1266
148. Nitkin R.M., Smith M.A., Magill C., Fallon J.R., Yao Y.M., Wallace B.G., et al. Identification of agrin, a synaptic organizing protein form Torpedo electric organ. J Cell Biol 105 (1987) 2471-2478
149. Noguchi H., Sakamoto C., Wada K., Akamatsu T., Uchida T., Tatsuguchi A., et al. Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells. Gastroenterology 117 (1999) 1119-1127
150. O'Connor L.T., Lauterborn J.C., Gall C.M., and Smith M.A. Localization and alternative splicing of agrin mRNA in adult rat brain: transcripts encoding isoforms that aggregate acetylcholine receptors are not restricted to cholinergic regions. Neurochem Int 24 (1994) 301-316
151. Ozaki M., Sasner M., Yano R., Lu H.S., and Buonanno A. Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 390 (1997) 691-694
152. Ozaki M., Tohyama K., Kishida H., Buonanno A., Yano R., and Hashikawa T. Roles of neuregulin in synaptogenesis between mossy fibers and cerebellar granule cells. J Neurosci Res 59 (2000) 612-623
153. Park S.K., Solomon D., and Vartanian T. Growth factor control of CNS myelination. Dev Neurosci 23 (2001) 327-337
154. Parker M.W., Chen Y., Hallenbeck J.M., and Ford B.D. Neuregulin expression after focal stroke in the rat. Neurosci Lett 334 (2002) 169-172
155. Patel N.V., Acarregui M.J., Snyder J.M., Klein J.M., Sliwkowski M.X., and Kern J.A. Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro. Am J Respir Cell Mol Biol 22 (2000) 432-440
156. Peck J.A., and Stopa E.G. Agrin and microvascular damage in Alzheimer's disease. Med Health R I 85 (2002) 202-206
157. Peles E., and Yarden Y. Neu and its ligands: from an oncogene to neural factors. BioEssays 15 (1993) 815-824
158. Peles E., Bacus S.S., Koski R.A., Lu H.S., Wen D., Ogden S.G., et al. Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69 (1992) 205-216
159. Prevot V., Rio C., Cho G.J., Lomniczi A., Heger S., Neville C.M., et al. Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes. J Neurosci 23 (2003) 230-239
160. Raats C.J., Bakker M.A., Hoch W., Tamboer W.P., Groffen A.J., van den Heuvel L.P., et al. Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem 273 (1998) 17832-17838
161. Raats C.J., Luca M.E., Bakker M.A., Van Der Wal A., Heeringa P., Van Goor H., et al. Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis [In Process Citation]. J Am Soc Nephrol 10 (1999) 1689-1699
162. Raats C.J., van den Born J., Bakker M.A., Oppers-Walgreen B., Pisa B.J., Dijkman H.B., et al. Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol 156 (2000) 1749-1765
163. Raff M.C., Abney E., Brockes J.P., and Hornby-Smith A. Schwann cell growth factors. Cell 15 (1978) 813-822
164. Rascher G., Fischmann A., Kroger S., Duffner F., Grote E.H., and Wolburg H. Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin. Acta Neuropathol (Berl) 104 (2002) 85-91
165. Rentschler S., Zander J., Meyers K., France D., Levine R., Porter G., et al. Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc Natl Acad Sci U S A 99 (2002) 10464-10469
166. Rieff H.I., Raetzman L.T., Sapp D.W., Yeh H.H., Siegel R.E., and Corfas G. Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J Neurosci 19 (1999) 10757-10766
167. Rio C., Rieff H.I., Qi P., Khurana T.S., and Corfas G. Neuregulin and erbB receptors play a critical role in neuronal migration. Neuron 19 (1997) 39-50
168. Rohrbach S., Yan X., Weinberg E.O., Hasan F., Bartunek J., Marchionni M.A., et al. Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors. Circulation 100 (1999) 407-412
169. Ross J.S., and Fletcher J.A. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Oncologist 3 (1998) 237-252
170. Ruegg M.A., Tsim K.W., Horton S.E., Kroger S., Escher G., Gensch E.M., et al. The agrin gene codes for a family of basal lamina proteins that differ in function and distribution. Neuron 8 (1992) 865-868
171. Rupp F., Payan D.G., Magill-Solc C., Cowan D.M., and Scheller R.H. Structure and expression of a rat agrin. Neuron 6 (1991) 869-878
172. Rusnak D.W., Affleck K., Cockerill S.G., Stubberfield C., Harris R., Page M., et al. The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer. Cancer Res 61 (2001) 7196-7203
173. Sanderson R.D., Yang Y., Kelly T., MacLeod V., Dai Y., and Theus A. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies. J Cell Biochem 96 (2005) 897-905
174. Sasisekharan R., Shriver Z., Venkataraman G., and Narayanasami U. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2 (2002) 521-528
175. Serpinskaya A.S., Feng G., Sanes J.R., and Craig A.M. Synapse formation by hippocampal neurons from agrin-deficient mice. Dev Biol 205 (1999) 65-78
176. Shah N.M., Marchionni M.A., Isaacs I., Stroobant P., and Anderson D.J. Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 77 (1994) 349-360
177. Silberberg G., Darvasi A., Pinkas-Kramarski R., and Navon R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet 141 (2006) 142-148
178. Slamon D., and Pegram M. Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials. Semin Oncol 28 (2001) 13-19
179. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., and McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177-182
180. Sliwkowski M.X., Lofgren J.A., Lewis G.D., Hotaling T.E., Fendly B.M., and Fox J.A. Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). Semin Oncol 26 (1999) 60-70
181. Smith M.A., and Hilgenberg L.G. Agrin in the CNS: a protein in search of a function?. NeuroReport 13 (2002) 1485-1495
182. Sparano J.A. Cardiac toxicity of trastuzumab (Herceptin): implications for the design of adjuvant trials. Semin Oncol 28 (2001) 20-27
183. Spence H.J., Dhillon A.S., James M., and Winder S.J. Dystroglycan, a scaffold for the ERK-MAP kinase cascade. EMBO Rep 5 (2004) 484-489
184. Staub O., and Rotin D. Regulation of ion transport by protein-protein interaction domains. Curr Opin Nephrol Hypertens 6 (1997) 447-454
185. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71 (2002) 877-892
186. Stefansson H., Sarginson J., Kong A., Yates P., Steinthorsdottir V., Gudfinnsson E., et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 72 (2003) 83-87
187. Stefansson H., Steinthorsdottir V., Thorgeirsson T.E., Gulcher J.R., and Stefansson K. Neuregulin 1 and schizophrenia. Ann Med 36 (2004) 62-71
188. Suarez E., Bach D., Cadefau J., Palacin M., Zorzano A., and Guma A. A novel role of neuregulin in skeletal muscle. Neuregulin stimulates glucose uptake, glucose transporter translocation, and transporter expression in muscle cells. J Biol Chem 276 (2001) 18257-18264
189. Sugita S., Saito F., Tang J., Satz J., Campbell K., and Sudhof T.C. A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol 154 (2001) 435-445
190. Tansey M.G., Chu G.C., and Merlie J.P. ARIA/HRG regulates AChR epsilon subunit gene expression at the neuromuscular synapse via activation of phosphatidylinositol 3-kinase and Ras/MAPK pathway. J Cell Biol 134 (1996) 465-476
191. Tatrai P., Dudas J., Batmunkh E., Mathe M., Zalatnai A., Schaff Z., et al. Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma. Lab Invest 86 (2006) 1149-1160
192. Tinsley J.M., Potter A.C., Phelps S.R., Fisher R., Trickett J.I., and Davies K.E. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene [see comments]. Nature 384 (1996) 349-353
193. Tokita Y., Keino H., Matsui F., Aono S., Ishiguro H., Higashiyama S., et al. Regulation of neuregulin expression in the injured rat brain and cultured astrocytes. J Neurosci 21 (2001) 1257-1264
194. Tournell C.E., Bergstrom R.A., and Ferreira A. Progesterone-induced agrin expression in astrocytes modulates glia-neuron interactions leading to synapse formation. Neuroscience 141 (2006) 1327-1338
195. Tourtellotte W.G., and Milbrandt J. Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. Nat Genet 20 (1998) 87-91
196. Toyoda-Ohno H., Obinata M., and Matsui Y. Members of the ErbB receptor tyrosine kinases are involved in germ cell development in fetal mouse gonads. Dev Biol 215 (1999) 399-406
197. Trachtenberg J.T., and Thompson W.J. Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor. Nature 379 (1996) 174-177
198. Tsen G., Halfter W., Kroger S., and Cole G.J. Agrin is a heparan sulfate proteoglycan. J Cell Biol 128 (1995) 1121-1129
199. Tsen G., Napier A., Halfter W., and Cole G.J. Identification of a novel alternatively spliced agrin mRNA that is preferentially expressed in non-neuronal cells. Science 269 (1995) 362-363
200. Tsim K.W., Ruegg M.A., Escher G., Kroger S., and McMahan U.J. cDNA that encodes active agrin [published erratum appears in Neuron 1992 Aug;9(2):following 381]. Neuron 8 (1992) 691-699
201. Uray I.P., Connelly J.H., Thomazy V., Shipley G.L., Vaughn W.K., Frazier O.H., et al. Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart. J Heart Lung Transplant 21 (2002) 771-782
202. Usdin T.B., and Fischbach G.D. Purification and characterization of a polypeptide from chick brain that promotes the accumulation of acetylcholine receptors in chick myotubes. J Cell Biol 103 (1986) 493-507
203. Valenzuela D.M., Stitt T.N., DiStefano P.S., Rojas E., Mattsson K., Compton D.L., et al. Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron 15 (1995) 573-584
204. van de Lest C.H., Versteeg E.M., Veerkamp J.H., and van Kuppevelt T.H. Digestion of proteoglycans in porcine pancreatic elastase-induced emphysema in rats. Eur Respir J 8 (1995) 238-245
205. van den Hoven M.J., Rops A.L., Bakker M.A., Aten J., Rutjes N., Roestenberg P., et al. Increased expression of heparanase in overt diabetic nephropathy. Kidney Int 70 (2006) 2100-2108
206. van Horssen J., Kleinnijenhuis J., Maass C.N., Rensink A.A., Otte-Holler I., David G., et al. Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging 23 (2002) 537-545
207. Vartanian T., Corfas G., Li Y., Fischbach G.D., and Stefansson K. A role for the acetylcholine receptor-inducing protein ARIA in oligodendrocyte development. Proc Natl Acad Sci U S A 91 (1994) 11626-11630
208. Vartanian T., Fischbach G., and Miller R. Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proc Natl Acad Sci U S A 96 (1999) 731-735
209. Verbeek M.M., Otte-Holler I., van den Born J., van den Heuvel L.P., David G., Wesseling P., et al. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am J Pathol 155 (1999) 2115-2125
210. Viehover A., Miller R.H., Park S.K., Fischbach G., and Vartanian T. Neuregulin: an oligodendrocyte growth factor absent in active multiple sclerosis lesions. Dev Neurosci 23 (2001) 377-386
211. Warth A., Kroger S., and Wolburg H. Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae. Acta Neuropathol (Berl) 107 (2004) 311-318
212. Wolpowitz D., Mason T.B., Dietrich P., Mendelsohn M., Talmage D.A., and Role L.W. Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses. Neuron 25 (2000) 79-91
213. Woo R.S., Li X.M., Tao Y., Carpenter-Hyland E., Huang Y.Z., Weber J., et al. Neuregulin-1 enhances depolarization-induced GABA release. Neuron 54 (2007) 599-610
214. Xia W., Mullin R.J., Keith B.R., Liu L.H., Ma H., Rusnak D.W., et al. Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways. Oncogene 21 (2002) 6255-6263
215. +-ATPase synergistically aggravates ceramide- and beta-amyloid-induced apoptosis in cortical neurons. Brain Res 955 (2002) 253-259
216. Xu Z., and Ford B.D. Upregulation of erbB receptors in rat brain after middle cerebral arterial occlusion. Neurosci Lett 375 (2005) 181-186
217. Xu Z., Ford G.D., Croslan D.R., Jiang J., Gates A., Allen R., et al. Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression. Neurobiol Dis 19 (2005) 461-470
218. Xu X., Fu A.K., Ip F.C., Wu C.P., Duan S., Poo M.M., et al. Agrin regulates growth cone turning of Xenopus spinal motoneurons. Development 132 (2005) 4309-4316
219. Yang Y., Spitzer E., Meyer D., Sachs M., Niemann C., Hartmann G., et al. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 131 (1995) 215-226
220. Yang S.H., Armson P.F., Cha J., and Phillips W.D. Clustering of GABAA receptors by rapsyn/43kD protein in vitro. Mol Cell Neurosci 8 (1997) 430-438
221. Yang X., Kuo Y., Devay P., Yu C., and Role L. A cysteine-rich isoform of neuregulin controls the level of expression of neuronal nicotinic receptor channels during synaptogenesis. Neuron 20 (1998) 255-270
222. Yang X., Arber S., William C., Li L., Tanabe Y., Jessell T.M., et al. Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron 30 (2001) 399-410
223. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2 (2001) 127-137
224. Yoshida M., and Ozawa E. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem (Tokyo) 108 (1990) 748-752
225. Zhang D., Sliwkowski M.X., Mark M., Frantz G., Akita R., Sun Y., et al. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci U S A 94 (1997) 9562-9567
226. Zhao Y.Y., Sawyer D.R., Baliga R.R., Opel D.J., Han X., Marchionni M.A., et al. Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 273 (1998) 10261-10269